Corporate DisclosureIBP
IBP Corporate Disclosure — 2 May 2021
Announcement summary
- What happened
- IBP published a corporate disclosure on 2 May 2021. Read the full announcement for details.
- Company
- Indo-Bangla Pharmaceuticals Limited
- Announcement published
Original announcement
(Continuation news of IBP) and marketing of all licensed items and cancelling the registration of 8 (eight) articles temporally by Directorate General of Drug Administration (DGDA). They also informed that in the meantime, DGDA has withdrawn the temporary suspension order. They also informed that operating expenses, depreciation expenses, finance charge and allowance of selling and distribution expenses increased during the reporting period (end).
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b000040053aff
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from IBP
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.